Skip to main content
Addgene

pGL4.10-VEGFprom(-1000 to -1) Citations (6)

Originally described in: Thyroid Transcription Factor 1 Reprograms Angiogenic Activities of Secretome.
Wood LW, Cox NI, Phelps CA, Lai SC, Poddar A, Talbot C Jr, Mu D Sci Rep. 2016 Feb 25;6:19857. doi: 10.1038/srep19857.
PubMed Journal

Articles Citing pGL4.10-VEGFprom(-1000 to -1)

Articles
Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance. Zhang H, Fredericks T, Xiong G, Qi Y, Rychahou PG, Li JD, Pihlajaniemi T, Xu W, Xu R. Breast Cancer Res. 2018 Oct 1;20(1):116. doi: 10.1186/s13058-018-1030-y. PubMed
HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1. Zanin R, Pegoraro S, Ros G, Ciani Y, Piazza S, Bossi F, Bulla R, Zennaro C, Tonon F, Lazarevic D, Stupka E, Sgarra R, Manfioletti G. J Exp Clin Cancer Res. 2019 Jul 16;38(1):313. doi: 10.1186/s13046-019-1307-8. PubMed
Direct inhibition of the TLR4/MyD88 pathway by geniposide suppresses HIF-1alpha-independent VEGF expression and angiogenesis in hepatocellular carcinoma. Zhang C, Wang N, Tan HY, Guo W, Chen F, Zhong Z, Man K, Tsao SW, Lao L, Feng Y. Br J Pharmacol. 2020 Jul;177(14):3240-3257. doi: 10.1111/bph.15046. Epub 2020 Apr 12. PubMed
Ionizing Radiation-Induced GDF15 Promotes Angiogenesis in Human Glioblastoma Models by Promoting VEGFA Expression Through p-MAPK1/SP1 Signaling. Park H, Nam KS, Lee HJ, Kim KS. Front Oncol. 2022 Feb 25;12:801230. doi: 10.3389/fonc.2022.801230. eCollection 2022. PubMed
Cooperative interaction between ERalpha and the EMT-inducer ZEB1 reprograms breast cancer cells for bone metastasis. Mohammadi Ghahhari N, Sznurkowska MK, Hulo N, Bernasconi L, Aceto N, Picard D. Nat Commun. 2022 Apr 19;13(1):2104. doi: 10.1038/s41467-022-29723-5. PubMed
NRN1 interacts with Notch to increase oncogenic STAT3 signaling in melanoma. Devitt L, Westphal D, Pieger K, Schneider N, Bosserhoff AK, Kuphal S. Cell Commun Signal. 2024 May 6;22(1):256. doi: 10.1186/s12964-024-01632-8. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.